MODERN CONCEPTS OF TREATMENT OF ENDOMETRITIS WITH CLINICAL APPLICATION OF PLATELET-RICH PLASMA IN THE FEMALE REPRODUCTIVE SYSTEM
##semicolon##
Keywords: gynaecology; platelet-rich plasma; infertility; endometrium; uterus##article.abstract##
Annotation: Platelet-rich plasma is an autologous plasma containing platelets prepared from fresh whole blood drawn from a peripheral vein. Through processing, it can be prepared to contain supraphysiologic levels of platelets at three to five times greater than the level of normal plasma. PRP has been explored both in vivo and ex vivo in the human endometrium model in its ability to harness the intrinsic regenerative capacity of the endometrium. Intrauterine autologous PRP infusions have been shown to increase endometrial thickness and reduce the rate of intrauterine adhesions. In the setting of recurrent implantation failure, intrauterine infusion of PRP has been shown to increase clinical pregnancy rate. PRP also appears to hold a potential role in select patients with premature ovarian insufficiency, poor ovarian responders and in improving outcomes following frozen–thawed transplantation of autologous ovarian tissue. Further studies are required to explore the potential role of PRP in reproductive medicine further, to help standardise PRP protocols and evaluate which routes of administration are most effective.
##submission.citations##
1. Alves, R.; Grimalt, R. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Ski. Appendage Disord. 2018, 4, 18–24.
2. Gupta, S.; Paliczak, A.; Delgado, D. Evidence-based indications of platelet-rich plasma therapy. Expert Rev. Hematol. 2021, 14, 97–108.
3. Amable, P.R.; Carias, R.B.V.; Teixeira, M.V.T.; da Cruz Pacheco, Í.; Amaral, R.J.F.C.D.; Granjeiro, J.M.; Borojevic, R. Platelet-rich plasma preparation for regenerative medicine: Optimization and quantification of cytokines and growth factors. Stem Cell Res. Ther. 2013, 4, 67.
4. Marx, R.E. Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant. Dent. 2001, 10, 225–228.
5. Lee, J.W.; Kwon, O.H.; Kim, T.K.; Cho, Y.K.; Choi, K.Y.; Chung, H.Y.; Cho, B.C.; Yang, J.D.; Shin, J.H. Platelet-rich plasma: Quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups. Arch. Plast. Surg. 2013, 40, 530–535.
6. Opneja, A.; Kapoor, S.; Stavrou, E.X. Contribution of platelets, the coagulation and fibrinolytic systems to cutaneous wound healing. Thromb. Res. 2019, 179, 56–63.
7. Matsumoto, H.; Nasu, K.; Nishida, M.; Ito, H.; Bing, S.; Miyakawa, I. Regulation of proliferation, motility, and contractility of human endometrial stromal cells by platelet-derived growth factor. J. Clin. Endocrinol. Metab. 2005, 90, 3560–3567.
8. Perovic, M.D.; Sudar-Milovanovic, E.M.; Simonovic, E.D.; Resanovic, I.M.; Draganic, V.D.; Radakovic, J.D.; Soldatovic, I.A.; Isenovic, E.R. Hypothesis regarding the effects of gonadotropins on the level of free fatty acids and phospholipids in serum and follicular fluid during controlled ovarian stimulation. Med. Hypotheses 2019, 123, 30–34.
9. Tokumura, A.; Miyake, M.; Nishioka, Y.; Yamano, S.; Aono, T.; Fukuzawa, K. Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of In vitro fertilization patients. Biol. Reprod. 1999, 61, 195–199.
10. Fayezi, S.; Darabi, M.; Darabi, M.; Nouri, M.; Rahimipour, A.; Mehdizadeh, A. Analysis of follicular fluid total phospholipids in women undergoing in-vitro fertilisation. J. Obstet. Gynaecol. 2014, 34, 259–262.
11. Moore, G.W.; Maloney, J.C.; Archer, R.A.; Brown, K.L.; Mayger, K.; Bromidge, E.S.; Najafi, M.F. Platelet-rich plasma for tissue regeneration can be stored at room temperature for at least five days. Br. J. Biomed. Sci. 2017, 74, 71–77.
12. Dhurat, R.; Sukesh, M. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author’s Perspective. J. Cutan. Aesthetic Surg. 2014, 7, 189–197.
13. Everts, P.; Onishi, K.; Jayaram, P.; Lana, J.F.; Mautner, K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int. J. Mol. Sci. 2020, 21, 7794.
14. Rughetti, A.; Giusti, I.; D’Ascenzo, S.; Leocata, P.; Carta, G.; Pavan, A.; Dell’Orso, L.; Dolo, V. Platelet gel-released supernatant modulates the angiogenic capability of human endothelial cells. Blood Transfus. 2008, 6, 12–17.
15. Dohan Ehrenfest, D.M.; Rasmusson, L.; Albrektsson, T. Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009, 27, 158–167.
16. Chang, Y.; Li, J.; Chen, Y.; Wei, L.; Yang, X.; Shi, Y.; Liang, X. Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int. J Clin. Exp. Med. 2015, 8, 1286–1290.
17. Zadehmodarres, S.; Salehpour, S.; Saharkhiz, N.; Nazari, L. Treatment of thin endometrium with autologous platelet-rich plasma: A pilot study. JBRA Assist. Reprod. 2017, 21, 54–56.
18. Zhu, R.; Gan, L.; Wang, S.; Duan, H. A cohort study comparing the severity and outcome of intrauterine adhesiolysis for Asherman syndrome after first- or second-trimester termination of pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2019, 238, 49–53.
19. Asherman, J.G. Traumatic intra-uterine adhesions. BJOG Int. J. Obstet. Gynaecol. 1950, 57, 892–896.
20. Puente Gonzalo, E.; Alonso Pacheco, L.; Vega Jiménez, A.; Vitale, S.G.; Raffone, A.; Laganà, A.S. Intrauterine infusion of platelet-rich plasma for severe Asherman syndrome: A cutting-edge approach. Updates Surg. 2021, 73, 2355–2362.
